A 'Universal' COVID Vaccine Could Save Billions If Another Pandemic Strikes

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 12, 2024.

By Dennis Thompson HealthDay Reporter

FRIDAY, Jan. 12, 2024 -- A universal coronavirus vaccine could have saved millions of lives and billions of dollars if one had been available prior to the pandemic, a new study argues.

Further, a universal vaccine -- one that targets parts of the virus common to all coronaviruses -- could still be a game-changer in the future, researchers say.

But that's only possible if one is developed before another variant mutates and runs rampant through the human population.

"COVID-19 was the third major and serious coronavirus epidemic or pandemic following SARS in 2002 and MERS in 2012, thus, we should anticipate a fourth coronavirus outbreak within the next decade or so,” said researcher Dr. Peter Hotez, dean of Baylor College’s National School of Tropical Medicine and co-director of the Texas Children’s Hospital Center for Vaccine Development.

"A universal vaccine is cost-effective and cost-saving, and a priority for advancement," Hotez added.

To figure out the potential value of having had a universal vaccine at the start of the pandemic, Hotez and his colleagues developed a computer model that simulated the entire U.S. population through the introduction and spread of COVID in 2020.

Specifically, the simulation weighed what might have happened if a universal coronavirus vaccine had been available at the start.

As history shows, scientists developed a strain-specific COVID vaccine in record time, but that still left 10 months of unchecked infection, illness and death.

Using the simulation, researchers determined that a universal vaccine would have saved money even if it had only been 10% effective against COVID and a minority of the populace had received the jab.

For example, a vaccine with 10% efficacy administered to a quarter of the U.S. population within two months of the start of the pandemic would have averted 14.6 million infections and saved more than $27 billion in direct medical costs, researchers estimate.

The benefits of a universal coronavirus vaccine would have held even if pharmaceutical companies had later crafted a better, more variant-specific vaccine, the model showed.

The findings were published Jan. 11 in the journal eClinicalMedicine.

"Our study shows the importance of giving as many people as possible in a population at least some degree of immune protection as soon as possible," said researcher Dr. Bruce Lee, a professor at the CUNY Graduate School of Public Health and Health Policy in New York.

"Having a universal vaccine developed, stockpiled and ready to go in the event of a pandemic could be a game-changer, even if a more specific vaccine could be developed three to four months later,” Lee added in a CUNY news release.

Sources

  • CUNY Graduate School of Public Health and Health Policy, news release, Jan. 11, 2024

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2024-01-13 02:15

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords